CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-08-23 | Chen Timothy Yung-Cheng Director | Sale | −286 | $143.01 | $41K | 7,614 |
| 2019-08-23 | Chen Timothy Yung-Cheng Director | Sale | −6,700 | $145.08 | $972K | 914 |
| 2019-08-23 | Chen Timothy Yung-Cheng Director | Sale | −200 | $146.36 | $29K | 714 |
| 2019-08-23 | Chen Timothy Yung-Cheng Director | Sale | −714 | $145.30 | $104K | 0 |
| 2019-08-23 | Chen Timothy Yung-Cheng Director | Exercise or conversion · Share Option (Right to Buy) | +102,700 | 357,926 | ||
| 2019-08-12 | Glazer Donald W. Director | Other disposition | −13,384 | 0 | ||
| 2019-08-12 | Glazer Donald W. Director | Other disposition | −26,100 | 3,711,426 | ||
| 2019-08-12 | Huang Jane CMO, Hematology | Exercise or conversion | +2,500 | $45.31 | $113K | 2,500 |
| 2019-08-12 | Huang Jane CMO, Hematology | Sale | −800 | $132.47 | $106K | 1,700 |
| 2019-08-12 | Huang Jane CMO, Hematology | Sale | −400 | $134.34 | $54K | 1,300 |
| 2019-08-12 | Huang Jane CMO, Hematology | Sale | −800 | $135.86 | $109K | 500 |
| 2019-08-12 | Huang Jane CMO, Hematology | Sale | −500 | $136.91 | $68K | 0 |
| 2019-08-12 | Huang Jane CMO, Hematology | Exercise or conversion · Share Option (Right to Buy) | +32,500 | 850,465 | ||
| 2019-07-29 | Huang Jane CMO, Hematology | Exercise or conversion | +5,000 | $45.31 | $227K | 5,000 |
| 2019-07-29 | Huang Jane CMO, Hematology | Exercise or conversion | +5,130 | $29.49 | $151K | 10,130 |
| 2019-07-29 | Huang Jane CMO, Hematology | Sale | −2,500 | $132.83 | $332K | 7,630 |
| 2019-07-29 | Huang Jane CMO, Hematology | Sale | −7,630 | $135.10 | $1.0M | 0 |
| 2019-07-29 | Huang Jane CMO, Hematology | Exercise or conversion · Share Option (Right to Buy) | +65,000 | 882,965 | ||
| 2019-07-29 | Huang Jane CMO, Hematology | Exercise or conversion · Share Option (Right to Buy) | +66,690 | 1,044,775 | ||
| 2019-07-08 | OYLER JOHN Chief Executive Officer | Sale | −1,200 | $125.59 | $151K | 1,906 |
Page 100 of 123 · 2,455 trades